Draft:American Gene Technologies

American Gene Technologies
Company typePrivate company
Industry
Founded2007 (2007)
FounderJeff Galvin
HeadquartersRockville, Maryland, USA
Area served
Worldwide
Key people
  • Jeff Galvin (CEO)
  • Jeff Boyle, PhD (CSO)
  • Marcus Conant, MD (CMO)
  • Drew Palin, MD (CBO)
Number of employees
50 (2023)
Subsidiaries
Addimmune
Websitewww.americangene.com

American Gene Technologies (AGT) is an American biotechnology company based in Rockville, Maryland[1]. AGT was founded in 2007 after founder and CEO was introduced to viral vectors by NIH researcher Roscoe Brady MD, PhD and decided that he wanted to help continue Brady's research[2]. The company focuses of gene therapy technologies, including but not limited to research into HIV, PKU, and immuno-oncology.

  1. ^ "American Gene Technologies: A Gene Therapy Biotech Company". American Gene Technologies. Retrieved 2023-07-17.
  2. ^ "American Gene Technologies | Maryland Business Success Story". business.maryland.gov. Retrieved 2023-07-17.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne